Literature DB >> 6448644

Fc-receptor-bearing cells in spleen of mice injected with cell-free Ehrlich ascites fluid (EAF).

J Gabrilovac, K Pachmann, S Thierfelder.   

Abstract

The kinetics of different cell populations (T and B) and subpopulations (one bearing easily releasable FcR and one bearing stable FcR) was followed in spleens of mice after one single i.p. injection of EAF. The number of FcR bearing cells doubled within 2-7 days after EAF injection. This increase was due to cells bearing temperature sensitive FcR and was accompanied by the doubling of theta positive cells. These results, supported by the demonstration of doubly labeled (theta+FcR+) cells, suggest that EAF injected into normal mice causes the appearance of T-cells expressing easily releasable FcR. These cells, according to Fridman et al. (1977) are suppressor cells. Maximal increase of theta positive cells and of cells with temperature sensitive FcR detected in vitro coincided with the maximum of the suppressive activity of EAF detected in vivo.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6448644     DOI: 10.1007/bf01020527

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  17 in total

1.  Mechanism of the immunosuppressive effect of Ehrlich ascitic tumour.

Authors:  I Hrsak; T Marotti
Journal:  Eur J Cancer       Date:  1975-03       Impact factor: 9.162

2.  Isolation of an immunosuppressive peptide fraction from the serum of cancer patients.

Authors:  R B Nimberg; A H Glasgow; J O Menzoian; M B Constantian; S R Cooperband; J A Mannick; K Schmid
Journal:  Cancer Res       Date:  1975-06       Impact factor: 12.701

3.  Suppressor cells in the spleens of tumor-bearing mice: enrichment by centrifugation on hypaque-ficoll and characterization of the suppressor population.

Authors:  B L Pope; R B Whitney; J G Levy; D G Kilburn
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

4.  The role of the Fc receptor (FcR) of thymus-derived lymphocytes. II. Presence of FcR on suppressor cells and direct involvement in suppression.

Authors:  W H Fridman; D Fradelizi; A Guimezanes; C Plater; J C Leclerc
Journal:  Eur J Immunol       Date:  1977-08       Impact factor: 5.532

5.  Suppressor cell population in Sézary syndrome.

Authors:  E Kansu; S P Hauptman
Journal:  Clin Immunol Immunopathol       Date:  1979-03

6.  Reversibility of the immunodepression due to Ehrlich ascites carcinoma.

Authors:  P Mocarelli; M L Villa; G Garotta; C Porta; G Bigi; E Clerici
Journal:  J Immunol       Date:  1973-09       Impact factor: 5.422

7.  Serum-mediated immunosuppression in lung cancer.

Authors:  A E Giuliano; D Rangel; S H Golub; E C Holmes; D L Morton
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

8.  Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.

Authors:  S M Hillinger; G P Herzig
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

9.  Characterization of suppressor cells in mice bearing syngeneic mastocytoma.

Authors:  F Takei; J G Levy; D G Kilburn
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

10.  Suppression of in vitro antibody synthesis by immunoglobulin-binding factor.

Authors:  R H Gisler; W H Fridman
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.